Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?

被引：0
|
作者：
Valk, Peter J. M. [1 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
AML; MDS-EB; TP53; mutation; outcome; ALLELE FREQUENCY; MUTATIONS; OUTCOMES;
D O I：
10.1016/S2152-2650(22)00640-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S3 / S5
页数：3
相关论文
共 50 条
  • [31] Expression of wild-type and mutated TP53 in breast carcinomas
    Baumbusch, LO
    Myhre, S
    Langerod, A
    Bergamaschi, A
    Johnsen, H
    Geisler, S
    Lonning, PE
    Borresen-Dale, AL
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S53 - S53
  • [32] TP53 mutations and MDS - not as easy as it seems
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 7 - 8
  • [33] TP53 binding protein-1 and mutated in Ataxia-Telangiectasia gene variants affect TP53 mutations in lung cancer
    Zienolddiny, S.
    Skaug, V.
    Haugen, A.
    EJC SUPPLEMENTS, 2010, 8 (05): : 225 - 225
  • [34] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    MODERN PATHOLOGY, 2018, 31 : 524 - 525
  • [35] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    LABORATORY INVESTIGATION, 2018, 98 : 524 - 525
  • [36] TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
    Hu, Wanglai
    Chen, Song
    Thorne, Rick F.
    Wu, Mian
    AUTOPHAGY: BIOLOGY AND DISEASES: BASIC SCIENCE, 2019, 1206 : 127 - 149
  • [37] Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes
    Montalban-Bravo, Guillermo
    Kanagal-Shamanna, Rashmi
    Benton, Christopher B.
    Class, Caleb A.
    Chien, Kelly S.
    Sasaki, Koji
    Naqvi, Kiran
    Alvarado, Yesid
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Takahashi, Koichi
    Jabbour, Elias
    Borthakur, Gautham
    Pemmaraju, Naveen
    Konopleva, Marina
    Soltysiak, Kelly A.
    Pierce, Sherry R.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD ADVANCES, 2020, 4 (03) : 482 - 495
  • [38] TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
    Pabst, Gabriel
    Lind, Karin
    Graf, Ricarda
    Zebisch, Armin
    Stoelzel, Friedrich
    Doehner, Konstanze
    Heitzer, Ellen
    Reinisch, Andreas
    Sill, Heinz
    ANNALS OF HEMATOLOGY, 2020, 99 (03) : 653 - 655
  • [39] Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients
    Ferrari, Anna
    Fonzi, Eugenio
    Fontana, Maria Chiara
    Di Rora, Andrea Ghelli Luserna
    Manfrini, Marco
    Padella, Antonella
    Baldazzi, Carmen
    Papayannidis, Cristina
    Marconi, Giovanni
    Paolini, Stefania
    Guadagnuolo, Viviana
    Perricone, Margherita
    Robustelli, Valentina
    Imbrogno, Enrica
    Franchini, Eugenia
    Venturi, Claudia
    Zuffa, Elisa
    Abbenante, Maria Chiara
    Simonetti, Giorgia
    Testoni, Nicoletta
    Ottaviani, Emanuela
    Giovanni, Martinelli
    CANCER RESEARCH, 2017, 77
  • [40] TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
    Gabriel Pabst
    Karin Lind
    Ricarda Graf
    Armin Zebisch
    Friedrich Stölzel
    Konstanze Döhner
    Ellen Heitzer
    Andreas Reinisch
    Heinz Sill
    Annals of Hematology, 2020, 99 : 653 - 655
12345